Previous studies have demonstrated that p5091, which is a specific inhibitor of USP7, blocks cell proliferation of different types of cancers such as ovarian (Wang et al., 2017), prostate (Morra et al., 2017), and breast cancers (Xia at al., 2019). Here, USP7 is linked to breast carcinoma.